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Background: Suprarenal fixation is widely used in endovascular aneurysm repair. Numerous small, underpowered studies
have concluded that it does not increase the risk of renal impairment compared with infrarenal fixation. A recent
meta-analysis demonstrated that renal infarction is more common with suprarenal fixation, but the effect on renal
function remains unclear.
Methods: Electronic abstract databases, article reference lists, and conference proceedings were searched for series
reporting renal function data after suprarenal fixation. There was considerable study heterogeneity with respect to key
factors such as pre-existing renal dysfunction and length of follow-up. Authors were contacted to obtain individual
patient data for a pooled reanalysis using standardized criteria.
Results: Of 46 potentially relevant citations, only 11 were eligible for inclusion in the meta-analysis. Complete data sets
were available for four studies (1065 patients), with a median follow-up of 33 months. Kaplan-Meier curves were
constructed for postoperative renal impairment in the suprarenal fixation and infrarenal fixation groups and compared by
the log-rank test. Median time free of renal impairment was 38.5 months in the infrarenal fixation group compared with
32.4 months in the suprarenal fixation group (P  .0038). However, to account for significant methodologic differences,
further analysis was required using a Weibull regression model fitted in open Bayesian inference using Gibbs sampling
(BUGS). The pooled hazard ratio for deterioration of renal function after suprarenal fixation was 0.6 (95% confidence
interval, 0.3-10).
Conclusion: Currently available data are insufficient to determine the precise effect of suprarenal fixation on medium-term
renal function. Conventional Kaplan-Meier analysis of the pooled data set suggested that suprarenal fixation increased the
risk of renal dysfunction; however, the effect disappeared when sophisticated statistical modelling was performed to
account for study heterogeneity. A randomised controlled trial of suprarenal fixation may resolve this issue. ( J Vasc Surg
2008;47:1364-70.)Endovascular abdominal aortic aneurysm repair (EVAR)
has revolutionized the surgical management of aneurysmal
disease. The technique reduces hospital stay, complication
rates, and perioperative mortality compared with traditional
open surgical repair.1,2 Stable graft anchorage is essential to
prevent late complications due to proximal endoleaks or graft
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1364migration.3 The proximal abdominal aorta, which gives rise to
the mesenteric vessels, less frequently becomes aneurysmal
and thus constitutes an attractive zone for proximal endograft
fixation. As a consequence, several commercially available
endografts now incorporate suprarenal fixation, and its use has
been adopted as standard practice in many units.
Suprarenal fixation is generally held to be safe, with no
greater risk of adverse renal consequences than infrarenal
fixation.4 This assumption is based on a large number of
reports in the literature during the last few years; however,
most series are retrospective, report nonconsecutive pa-
tients, and are underpowered. Some studies provide no
comparison of suprarenal fixation with the infrarenal
alternative. Thus, the current clinical paradigm that su-
prarenal fixation does not cause harm is based on an
“absence of evidence” rather than “evidence of ab-
sence.”
To date, there has been a single meta-analysis of the
available literature. Sun and Stevenson5 identified a signif-
icant risk of renal infarction with suprarenal fixation
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8.420; P  .001). They were unable to identify any effect
on postoperative renal function, although they could only
identify four studies with sufficient data. Their attempts to
contact study authors for clarification of certain issues were
unsuccessful. Therefore, the conclusion that suprarenal
fixation does not affect renal function should be treated
with caution, particularly in view of the positive association
with renal infarction.
Since the preparation of this meta-analysis, several
more groups have published comparisons of postoperative
renal function with suprarenal and infrarenal fixation.3,6,7
We conducted a systematic review and obtained patient-
level data from relevant studies to determine whether su-
prarenal fixation increases the risk of post-EVAR renal
impairment.
METHODS
An electronic search of the Medline and EMBASE
databases between January 1991 and December 2006 was
performed. The search was started from 1991 because this
was the year that EVAR was first described in the literature.
Combinations of the search terms transrenal, suprarenal,
fixation, and endovascular were used to identify reports of
renal function after EVAR. We also conducted a hand
search of conference proceedings from the International
Congress of Endovascular Interventions (1998 to 2006),
the European Society for Vascular Surgery (2000 to 2006),
the Association of Surgeons of Great Britain and Ireland
(2000 to 2006), the Peripheral Vascular Surgery Society
(1998-2006), Society for Clinical Vascular Surgery (2005
and 2006) and the Vascular Society of Great Britain and
Ireland (2000 to 2006). Finally, the reference lists of pub-
lications identified by the search were scrutinized to obtain
any further publications.
The outcome of interest for the meta-analysis was
post-EVAR renal impairment after suprarenal fixation com-
pared with infrarenal fixation. Accordingly, publications
were eligible for inclusion in the meta-analysis provided
that they contained preoperative and postoperative renal
function data and compared suprarenal fixation with infra-
renal fixation. The quality of eligible studies was assessed
using the Downs and Black score.8 The maximum achiev-
able score is 31.
We initially intended to compare the incidence of post-
operative renal impairment between the suprarenal and
infrarenal fixation groups. However, an initial assessment of
the available data revealed considerable heterogeneity be-
tween the series with respect to length of follow-up, report-
ing of potential confounding variables, renal outcomemea-
sures used, and particularly, the definitions of renal
impairment used. As a consequence, we contacted the
authors of relevant series to obtain original, patient-level
data.
We then used the data obtained to reclassify each
patient using standardized criteria for renal impairment.
Preoperative renal impairment was defined as a serum cre-
atinine value 1.5 mg/dL or a creatinine clearance value60 mL/min. Postoperative renal impairment was defined
as 20% increase in serum creatinine above baseline, a
serum creatinine value 1.5 mg/dL, a 20% decrease in
creatinine clearance from baseline, or a decrease in creati-
nine clearance to60 mL/min. Patients were censored on
the date when postoperative renal impairment occurred or
on the date of their last hospital contact.
Kaplan-Meier curves were constructed to assess the
effect of preoperative renal impairment and suprarenal fix-
ation on the incidence of postoperative renal impairment
on the entire pooled cohort. The curves were compared
using the log-rank test. The 5% level was considered signif-
icant. Some series only recorded events at infrequent time
points. As a result, it was not possible to ignore the interval-
censored nature of these data.
This interval censoring may have contributed signifi-
cantly to the heterogeneity observed between the series. To
account for it, a Bayesian hierarchic Weibull regression
model was constructed using OpenBUGS (Bayesian infer-
ence usingGibbs sampling) software. Hazard wasmodelled
as: hazard     (if suprarenal fixation)   (if preoper-
ative renal impairment). This model was fitted to each data
set, with the  and  parameters being modelled as obser-
vations from the same distribution.
This model was fitted to each data set, with the  and 
parameters (as well as the shape parameter of the Weibull
distribution) being modelled as random effects from distri-
butions common to all of the studies. For purposes of
extrapolation, two terms were considered: the means of
those distributions to determine whether there is an overall
population effect, referred to in the tables as “overall
mean”, and additional values sampled from those distribu-
tions, indicative of values we would expect to see in a
hypothesized future study conducted on another subpopu-
lation, referred to in the Tables as “future study.”
This model was found to have the lowest deviance
information criterion measure of the potential models con-
sidered. We allowed 50,000 iterations of the model as a
burn-in. The estimates were then generated using 10,000
iterations of the model. The statistical analyses were con-
ducted using Statsdirect 2.5.7 (Statsdirect Ltd, Altrincham,
UK) for the Kaplan-Meier analyses and WinBUGS (open
source software, http://www.mrc-bsu.cam.ac.uk/bugs/)
for the regression modelling.
RESULTS
Literature review. The systematic review identified 46
potentially relevant citations from 1991 to 2006.3,5-7,9-50 We
found no randomized trials comparing the two fixationmeth-
ods. A number of publications were ineligible for inclusion for
various reasons. Five abstracts38-40,42,43 were excluded be-
cause they were subsequently published in full,3,6,12,20,30
one abstract contained no primary data,41 and one center
published three reports11,28,37 of its experience of suprare-
nal fixation, so only the most recent data were used.11 Two
articles were literature reviews,29,32 and one was a system-
atic review.5 Fourteen articles only presented data regarding
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and three series contained no renal outcome data.33-35 Two
reports from the same group compared suprarenal fixation
to open repair.19,48
This left 16 series that were cohort studies of both
infrarenal and suprarenal fixation.† One of these provided
no data on postprocedural renal function,35 and three series
contained both suprarenal and infrarenal fixation patients
but did not assess the impact of fixation on renal func-
tion.46,47,49 One series used the number of kidneys rather
than patients as the study denominator. We were unable to
contact the authors for clarification so this series was ex-
cluded.24 The remaining 11 studies were eligible for the
meta-analysis.‡
Study characteristics and quality. The characteristics
of the included studies are summarized in Table I (online
only). Most were retrospective. Quality scores ranged from
12 to 22, out of a maximum of 31, indicating that the
studies were only of moderate quality. Sample sizes ranged
from 14 to 604.More than half of the studies did not define
renal impairment,7,12,26,30,31,44 but the other five each
used distinct definitions.3,6,11,16,36 Most series did not
comprehensively report potential confounding factors such
as diabetes mellitus, pre-existing renal impairment, volume
*References 9, 10, 13-15, 17, 18, 20, 22, 23, 25, 27, 45,50.
†References 3, 6, 7, 11, 12, 16, 24, 26, 30, 31, 35, 36, 44, 46, 47, 49.
Fig 1. Risk of postoperative renal dysfunction suprarenal (1, black
line, diamonds) vs infrarenal (0, squares, red line) fixation.
Table II. Renal impairment in original articles and using s
Series (first author)
Suprarenal fixation g
Original S
Alsac6 41/137
Alric11 29/169
Bockler12 NS
Parmer3 6/79
Davey7 NS
NS, Not stated.‡References 3, 6, 7, 11, 12, 16, 26, 30, 31, 36, 44.of contrast used, and contrast nephropathy prophylaxis.
Several studies used appropriate statistical techniques to
account for variable follow-up,6,11,36 but most did not. In
view of the considerable heterogeneity between the series,
we contacted corresponding authors to obtain original
patient level data for a pooled reanalysis.
Collection of pooled data set. We received replies
from six of the 11 authors that we attempted to contact.
One group could not locate their data,16 and the remaining
five authors agreed to provide data to us.3,6,7,11,12 Com-
plete data sets for four studies were available.3,6,7,11 For the
remaining series, data were available for some patients but
not all.12 One group provided data on some additional
patients not included in their original publication.3 Authors
provided data on baseline serum creatinine or creatinine
clearance, type of fixation, postoperative renal function
indicators, and dates of renal function testing. No series
used direct measurement of the creatinine clearance. Cre-
atinine clearance was calculated using the Cockcroft-Gault
equation.51
We obtained data for 1151 patients undergoing EVAR
in which infrarenal or suprarenal fixation was used. Some
patients were excluded owing to incomplete data sets,
leaving 1065 patients for the pooled analysis. Suprarenal
fixation was used in 520 patients (49%). Preoperative renal
impairment (serum creatinine 1.5 mg/dL or estimated
glomerular filtration rate [eGFR] 60 mL/min, or both)
was present in 197 patients (18.5%). In 347 patients,
significant deteriorations in renal function occurred post-
operatively (increase in serum creatinine to 1.5 mg/L or
20% than baseline; fall in eGFR to 60 mL/min or 20%
fall from baseline). The results of the individual series are
summarized in Table II.
Kaplan-Meier survival analyses. Kaplan-Meier curves
were constructed to assess the potential effect of preopera-
tive renal impairment and suprarenal fixation on subse-
quent renal dysfunction. The median time free from post-
operative renal impairment was 38.5 months in the
infrarenal fixation group (95% confidence interval [CI],
33.8-43.4) compared with 32.4 months (95% CI, 28.3-
36.5 months) in the suprarenal fixation group (log-rank
test P  .0038; Fig 1). Preoperative renal impairment also
affected the risk of postoperative dysfunction. Median sur-
vival free of postoperative decline in renal function was 39.5
months (95% CI, 32.3-46.8 months) in patients with pre-
ardized definitions in series providing raw data
Infrarenal fixation group
rdized Original Standardized
137 35/135 40/135
167 24/146 42/139
21 NS 6/16
106 15/147 74/164
91 NS 23/89tand
roup
tanda
46/
42/
7/
47/
20/operative renal impairment compared with 32.4 months
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erative renal function (log-rank test P  .0001; Fig 2).
We then excluded all patients with follow-up of 1
month to eliminate any effect from transient postoperative
renal dysfunction. Median survival free from new renal im-
pairment was 37.3 months (95% CI, 34.4-40.2 months) in
the suprarenal fixation group compared with 45.2 months
(95% CI, 38.9-51.4 months) in the infrarenal fixation group
(log-rank test P .0385).
Bayesian hierarchic Weibull regression analysis.
The results are summarized in Table III. Using the
model, only Parmer and Carpenter’s3 cohort displayed a
significant effect from both suprarenal fixation and pre-
operative renal impairment. None of the other series
displayed a significant effect. We then excluded Parmer
and Carpenter’s cohort, as potential outliers, and re-
peated the modelling. Again, preoperative renal impair-
ment had no significant effect in the remaining series
(data not shown), nor was there any effect for suprarenal
fixation (Table IV). The overall pooled results (the fu-
ture hypothetic study results generated by the model)
suggest that there is no evidence that suprarenal fixation
increases the risk of postoperative renal dysfunction.
However, if Parmer and Carpenter’s cohort is considered
representative, there is evidence that in some subgroups
(ie, the patients included in Parmer and Carpenter’s
data), suprarenal fixation will have a detrimental effect.
We were unable to compare the effects of variables such
as contrast dose, hydration practices, and diabetes, dif-
ferences in which could account for the apparent effect of
Fig 2. Risk of postoperative renal dysfunction with preoperative
impairment (1, black line, diamonds) vs normal preoperative renal
function (0, squares, red line).suprarenal fixation in Parmer and Carpenter’s series.DISCUSSION
The pooled data set that we have compiled consider-
ably exceeds the sample size of any one individual study in
this area. The 1065 patients in the pooled data set represent
only 44% of the potential sample available had we been able
to contact all 11 authors. Would inclusion of the remaining
patients have altered the results from the pooled analysis?
We were unable to obtain any data from six studies, each of
which concluded that suprarenal fixation had no apparent
effect on renal function.16,26,30,31,36,44 Of the five series
from which data were pooled,3,6,7,11,12 four reached a sim-
ilar conclusion.3,7,11,38 Only Bockler et al12 concluded that
suprarenal fixation had an adverse effect on renal function.
We were only able to retrieve a small portion of their data
set. In fact, only 36 patients from the Bockler et al study
were included in the final pooled sample. Of these, 13
developed new postoperative renal impairment. Data from
the Bockler et al study represents only 3% of the pooled
sample. It seems unlikely that the inclusion of the Bockler
et al data have significantly biased our results.
The remaining four studies all concluded that suprare-
nal fixation had no effect on renal function.3,7,11,38 These
conclusions were contradicted by the pooled Kaplan-Meier
analysis, which identified a significant risk of renal dysfunc-
tion after suprarenal fixation. The first iteration of the
hierarchic regression model suggested that suprarenal fixa-
tion in the Parmer and Carpenter cohort was associated
with an increased risk.3 The discrepancies between the
conclusions of the original articles and our analysis are
probably the result of differing definitions of renal impair-
ment.
Alric et al11 defined postoperative renal impairment as a
20% rise in serum creatinine compared with baseline. Using
this definition, new postoperative renal impairment devel-
oped in 53 patients in their series. Including patients whose
serum creatinine increased above the standard threshold for
renal impairment of 150 mol/dL, we identified postop-
erative renal dysfunction in 83 of patients in the Alric et al
study. A similar effect was noted for Parmer and Carpen-
ter’s data.3 The original study used a definition of postop-
erative renal impairment of serum creatinine 150
mol/dL and a rise of 30% from baseline, which identi-
fied postoperative renal impairment in 21 patients. Using
the standardized definition, we identified postprocedural
renal impairment in 121 patients.
The differences in definition account for the disparity in
results, underlining the importance of using standard defi-
nitions in studies such as these. Most of the studies eligible
for the pooled analysis did not actually provide any defini-
tion of renal impairment, whereas those that did each used
a distinct definition, thus making it futile to attempt a
meta-analysis of the summary results. Estimated creatinine
clearance is a more sensitive indicator of renal dysfunction
than serum creatinine alone,52 but only three of the studies
in the pooled analysis calculated it.3,6,7 The other two series
only used serum creatinine.11,12 Individual patient weights
were not available, which prevented us from calculating the
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cluded serum creatinine values in our definition of renal
dysfunction for the pooled analysis. The United States
National Kidney Foundation recommends that eGFR be
used routinely for the identification of early renal dysfunc-
tion, with a cutoff of60 mL/min indicating renal impair-
ment.53 Future series investigating renal dysfunction after
suprarenal endograft fixation should use this definition.
Furthermore, the development of renal impairment is
an event that may only affect a percentage of the sample
cohort and is likely to occur at variable time intervals. Thus,
a comparison of summary serum creatinine data between
suprarenal and infrarenal groups is insufficient to determine
the effect on renal function. Kaplan-Meier or life-table
analysis should be applied to account for the effects of
variable follow-up on the apparent incidence of renal dys-
function.
Preoperative renal impairment is an important determi-
nant of postoperative renal dysfunction.6 Of interest was
that the univariate analysis of the pooled cohort found that
patients with normal preoperative renal function were at
increased risk of postoperative renal dysfunction. In the
Weibull regression model, only Parmer and Carpenter’s
cohort displayed a significant protective effect for preoper-
ative renal impairment. In their original publication, Alsac
et al6 reported a similar observation, although no such
effect was observed for their cohort in the Weibull models.
Hydration and minimal contrast volumes can reduce the
risk of renal impairment after contrast-enhanced proce-
dures.54 Less attention to hydration and more liberal con-
Table III. Results of Bayesian hierarchical regression mod
Series (first author) Suprarenal fixation HR
Alsac6 1.0
Alric11 1.3
Bockler12 1.6
Parmer3 3.9
Davey7 1.3
Future study 1.6
Overall mean 1.6
CI, Confidence interval; HR, hazard ratio.
Table IV. Results of Bayesian hierarchic regression
model with the Parmer and Carpenter cohort excluded as
an outlier
Series Suprarenal fixation HR 95% CI
Alsac6 1.1 0.9-1.5
Alric11 1.2 1.0-1.6
Bockler12 1.2 0.8-2.0
Parmer3 NA NA
Davey7 1.2 0.9-1.6
Future study 1.2 0.7-2.1
Overall mean 1.2 0.9-1.7
CI, Confidence interval; HR, hazard ratio.trast use in patients with normal preoperative renal functionmay account for the counterintuitive observation that nor-
mal function confers increased risk. We were unable to
obtain sufficient data to assess the effect of either contrast
dose or hydration policies on the pooled cohort.
CONCLUSIONS
Should the results of our pooled analysis alter the
prevailing clinical paradigm, that suprarenal fixation is
harmless? We have shown that this assumption is largely
based on retrospective analyses of nonconsecutive patients
with considerable variations in length of follow-up. The
definitions of renal impairment are inconsistent. Our uni-
variate analysis suggests that suprarenal fixation increases
the risk of renal impairment in the medium-term; however,
we urge caution in the interpretation of the Kaplan-Meier
analyses. The groups studied were quite heterogenous, and
for some series, censoring data were only available to the
nearest 3 months. As a consequence, some of the assump-
tions inherent in Kaplan-Meier analysis, such as sample
homogeneity and equal probability of censoring in both
groups, were not completely met. Moreover, Kaplan-Meier
analysis assigns a patient irrevocably to a particular group
once an event has occurred, in this case, renal impairment.
Previous work has demonstrated that many patients present
with renal impairment during the first 12 months after
EVAR but subsequently recover.19 The Kaplan-Meier anal-
ysis does not account for this. The apparent effect in the
Kaplan-Meier analyses does not persist in a hierarchic re-
gression model.
We have been unable to account for potential con-
founding factors such as contrast use, aneurysm neck anat-
omy, hydration, and comorbidities. The available data are
insufficient to accurately assess the effect of suprarenal
fixation. As a consequence, the current clinical paradigm on
the use of suprarenal fixation remains based on “an absence
of evidence” that the technique causes harm, rather than
concrete evidence that it is harmless. A large-scale random-
ized clinical trial of suprarenal vs infrarenal fixation is re-
quired to ensure that suprarenal fixation does no harm.
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First author, year SF IF Definition of renal impairmen
Parmer,3 2006 79 147 Increase in SCr 30% and an
absolute SCr value 1.5 mg/
or initiation of hemodialysis
Davey,7 2006 72 63 Not defined
Alsac,6 2005 137 135 20% decrease in CrCl
Mehta,31 2004 111 385 Not defined
Surowiec,36 2004 60 53 Increase in SCr of 20% over
baseline and an absolute SCr
value 1.5 mg/dL
Bockler,12 2003 202 402 Not defined
Cayne,16 2003 69 61 Increase in Scr 0.5 mg/dL vs
baseline value
Alric,11 2003 169 146 Increase in SCr of 20% vs base
Lau,26 2003 32 55 Not defined
Duda,44 1998 7 7 Not defined
Marin,30 1998 37 16 Not defined
CrCl, Creatinine clearance; IF, infrarenal fixation; SCr, serum creatinine; SFt
Primary renal function
outcome Prospective
Consecutive
patients
Quality
score
dL
Comparison of pre-op and
post-op SCr and CrCl
values
No No 20
Comparison of post-op
SCr and CrCl
No No 15
Post-op renal dysfunction Yes Yes 22
Comparison of mean pre-
op and post-op SCr and
CrCl values
No No 13
Post-op renal impairment No No 19
Mean post-op SCr values Yes Yes 19
Comparison of mean pre-
op and post-op Scr and
CrCl values
No No 15
line Post-op renal impairment Yes Yes 22
Comparison of pre-op and
post-op SCr values
No No 22
Comparison of pre-op and
post-op SCr values
Yes Yes 12
Comparison of pre-op and
post-op SCr values
Yes Yes 15
